Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma

  1. Auner, H.W.
  2. Gavriatopoulou, M.
  3. Delimpasi, S.
  4. Simonova, M.
  5. Spicka, I.
  6. Pour, L.
  7. Dimopoulos, M.A.
  8. Kriachok, I.
  9. Pylypenko, H.
  10. Leleu, X.
  11. Doronin, V.
  12. Usenko, G.
  13. Hajek, R.
  14. Benjamin, R.
  15. Dolai, T.K.
  16. Sinha, D.K.
  17. Venner, C.P.
  18. Garg, M.
  19. Stevens, D.A.
  20. Quach, H.
  21. Jagannath, S.
  22. Moreau, P.
  23. Levy, M.
  24. Badros, A.
  25. Anderson, L.D.
  26. Bahlis, N.J.
  27. Facon, T.
  28. Mateos, M.V.
  29. Cavo, M.
  30. Chai, Y.
  31. Arazy, M.
  32. Shah, J.
  33. Shacham, S.
  34. Kauffman, M.G.
  35. Richardson, P.G.
  36. Grosicki, S.
  37. Montrer des auteurs +
Revue:
American Journal of Hematology

ISSN: 1096-8652,  0361-8609

Année de publication: 2021

Volumen: 96

Número: 6

Pages: 708-718

Type: Article

DOI: 10.1002/AJH.26172 GOOGLE SCHOLAR lock_openAccès ouvert editor